The Home of Clinical Trials
MAC Clinical Research is one of Europe’s largest contract research organisations (CRO) and has headquarters in the UK. Owning a network of Dedicated Research Sites providing extensive reach, MAC also has offices within the EU and the US. Read more …
Latest Clinical Research News
Corporate
MAC Clinical Research Successfully Doses First Patient in Phase 2 Study for the Treatment of Social Anxiety Disorder
MAC Clinical Research is pleased to announce the successful dosing of the first participant in a Phase 2 clinical study
May 27, 2025
Corporate
Successful dosing of first cohort in Phase I MAD Study of KP405 in Collaboration with Kariya Pharmaceuticals
MAC Clinical Research and Kariya Pharmaceuticals are pleased to share the successful dosing of the first cohort in the Phase
May 16, 2025
Corporate
MAC Clinical Research Announces Clinical Development of Mavatrep, a TRPV1 Antagonist Analgesic Drug
MAC Clinical Research (MAC) announces regulatory approval to initiate a PII clinical trial for mavatrep, an investigational, oral, TRPV1-receptor (transient
May 15, 2025